EN HU

Doctoral School of Molecular Cellular and Immune Biology

Doctoral School of Molecular Cellular and Immune Biology
Doctoral School of Molecular Cellular and Immune Biology
Uploaded publications:
348
Publications in DEA:
348
OA:
248
Date range:
2004-2026
2026
1.
Ivanovics, B., Gazsi, G., Varga, Z. K., Staszny, Á., Váradi, E., Varga, Z., Ács, A., Tóth, M., Domokos, A., Reining, M., Vásárhelyi, E., Póliska, S., Kovács, R., Baska, F., Filep, Z., Bácsi, A., Kobolák, J., Urbányi, B., Szabó, I., Müller, T., Csenki-Bakos, Z., Czimmerer, Z.: Carbamate insecticide bendiocarb induces complex embryotoxic effects, including morphological, behavioral, transcriptional, and immunological alterations in zebrafish.
Comp. Biochem. Physiol. C-Toxicol. Pharmacol. 299, 1-18, (article identifier: 110368), 2026.
Journal metrics:
D1 Animal Science and Zoology (2024)
D1 Aquatic Science (2024)
Q2 Biochemistry (2024)
Q2 Cell Biology (2024)
Q1 Health, Toxicology and Mutagenesis (2024)
Q1 Medicine (miscellaneous) (2024)
Q2 Physiology (2024)
Q1 Toxicology (2024)
2.
Lengyel, M., Árkosy, P., Uray, I. P.: G protein subtype preference dictates paroxetine-enhanced serotonin receptor response in non-malignant breast epithelial cells.
Biochem. Pharmacol. 244, 1-16, (article identifier: 117584), 2026.
Journal metrics:
Q1 Biochemistry (2024)
Q1 Pharmacology (2024)
2025
3.
Szőke-Kovács, R., Khakoo, S., Rangel, V. L., Della Cristina, P., Pentier, J., Khanolkar, R., El-Ajouz, S., Simmons, R. A., Cole, D. K., Gogolák, P., Salio, M., Karuppiah, V.: A CD1c lipid agnostic T cell receptor bispecific engager redirects T cells against CD1c+ cells.
Front. Immunol. 16, 1-14, (article identifier: 1614610), 2025.
Journal metrics:
Q1 Immunology (2024)
Q1 Immunology and Allergy (2024)
4.
Jenei, V., Muszka, Z., Stigelmayer, Á., Debreceni, Z., Bácsi, A., Türk-Mázló, A., Koncz, G.: Anthracycline Treatments and the Presence of Tumor Cells Synergistically Modify the Composition of Macrophage Subpopulations in the Co-Culture System.
Int. J. Mol. Sci. 26 (18), 1-14, (article identifier: 9202), 2025.
Journal metrics:
Q2 Catalysis (2024)
Q1 Computer Science Applications (2024)
Q1 Inorganic Chemistry (2024)
Q1 Medicine (miscellaneous) (2024)
Q2 Molecular Biology (2024)
D1 Organic Chemistry (2024)
Q1 Physical and Theoretical Chemistry (2024)
D1 Spectroscopy (2024)
5.
Jambrovics, K., Al-Hadban, W., Türk-Mázló, A., Szatmári, I., Dobó, B., Reményi, G., Jóna, Á., Koncz, G., Balajthy, Z.: Anti-inflammatory 25(OH)D3, a natural steroid hormone, may complement all-trans retinoic acid therapy for differentiation syndrome in acute promyelocytic leukemia.
Cell Death Dis. 16 (1), 1-10, (article identifier: 787), 2025.
Journal metrics:
Q1 Cancer Research (2024)
Q1 Cell Biology (2024)
D1 Cellular and Molecular Neuroscience (2024)
Q1 Immunology (2024)
D1 Medicine (miscellaneous) (2024)
6.
Tornyi, I.: A plazma C9 epitópok heterogenitásának vizsgálata.
Biokémia. 49 (3), 38-43, 2025.
7.
Csatári-Kovács, R., Röszer, T., Csősz, É.: Comparative Analysis of Omega-3, Omega-6, and Endocannabinoid Content of Human, Cattle, Goat, and Formula Milk.
Foods. 14 (10), 1-14, (article identifier: 1786), 2025.
Journal metrics:
Q1 Food Science (2024)
D1 Health Professions (miscellaneous) (2024)
Q1 Health (social science) (2024)
Q2 Microbiology (2024)
Q1 Plant Science (2024)
8.
Bertalan, P. M., Nokhoijav, E., Pap, Á., Neagu, G. C., Káplár, M., Darula, Z., Kalló, G., Prokai, L., Csősz, É.: Comprehensive Insights into Obesity and Type 2 Diabetes from Protein Network, Canonical Pathway, Phosphorylation, and Antimicrobial Peptide Signatures of Human Serum.
Proteomes. 13 (4), 1-26, (article identifier: 67), 2025.
9.
Biwott, K., Singh, P., Baráth, S., Nyariki, J. N., Hevessy, Z., Bacsó, Z.: Dynamic P-glycoprotein expression in early and late memory states of human CD8+T cells and the protective role of ruxolitinib.
Biomed. Pharmacother. 182, 1-14, (article identifier: 117780), 2025.
Journal metrics:
D1 Medicine (miscellaneous) (2024)
D1 Pharmacology (2024)
10.
Gutierrez-Rus, L. I., Vos, E., Pantoja-Uceda, D., Hoffka, G., Gutierrez-Cardenas, J., Ortega-Munoz, M., Risso, V. A., Jimenez, M. A., Kamerlin, S. C. L., Sanchez-Ruiz, J. M.: Enzyme Enhancement Through Computational Stability Design Targeting NMR-Determined Catalytic Hotspots.
J. Am. Chem. Soc. 147 (18), 14978-14996, 2025.
Journal metrics:
D1 Biochemistry (2024)
D1 Catalysis (2024)
D1 Chemistry (miscellaneous) (2024)
D1 Colloid and Surface Chemistry (2024)
11.
Mianesaz, H., Göczi, L., Nagy, G., Póliska, S., Fadel, L., Bojcsuk, D., Penyige, A., Szirák, K., AlHaman, F., Nagy, L., Vámosi, G., Széles, L.: Genomic regions occupied by both RARα and VDR are involved in the convergence and cooperation of retinoid and vitamin D signaling pathways.
Nucleic Acids Res. 53 (6), 1-20, (article identifier: 230), 2025.
Journal metrics:
D1 Genetics (2024)
12.
Benhamza, I., Imre, L., Yu, Z., Nánási, P. P. i., Sen, P., Enyedi, K. N., Goda, K., Vámosi, G., Szabó, G.: H2A.Z-nucleosomes are stabilized by the superhelicity-dependent DNA binding of the C-terminal tail of the histone variant.
Nucleus. 16 (1), 1-14, (article identifier: 2557113), 2025.
Journal metrics:
Q1 Cell Biology (2024)
D1 Medicine (miscellaneous) (2024)
13.
Géczi, D., Klekner, Á., Balogh, I., Penyige, A., Szilágyi, M., Virga, J., Bakó, A., Nagy, B., Torner, B., Hádáné Birkó, Z.: Identification of Deregulated miRNAs and mRNAs Involved in Tumorigenesis and Detection of Glioblastoma Patients Applying Next-Generation RNA Sequencing.
Pharmaceuticals. 18 (3), 1-29, (article identifier: 431), 2025.
Journal metrics:
Q1 Drug Discovery (2024)
Q2 Molecular Medicine (2024)
Q1 Pharmaceutical Science (2024)
14.
Muszka, Z., Jenei, V., Mácsik, R., Mezhonova, E., Diyab, S., Csősz, R., Bácsi, A., Türk-Mázló, A., Koncz, G.: Life-threatening risk factors contribute to the development of diseases with the highest mortality through the induction of regulated necrotic cell death.
Cell Death Dis. 16 (1), 1-19, (article identifier: 273), 2025.
Journal metrics:
Q1 Cancer Research (2024)
Q1 Cell Biology (2024)
D1 Cellular and Molecular Neuroscience (2024)
Q1 Immunology (2024)
D1 Medicine (miscellaneous) (2024)
15.
Al-Muffti, A. S., Kiarie, I. W., Tőzsér, J., Mahdi, M.: Modulation of transferrin receptor by HIV-2.
Virol. J. 22 (1), 1-10, (article identifier: 382), 2025.
Journal metrics:
Q1 Infectious Diseases (2024)
Q2 Virology (2024)
16.
Halász, H. E., Papp, A. B., Lesinszki, L. S., Mócsai, A., Varga, T., Nagy, L., Gogolák, P.: Neutrophil deficiency increases T-cell numbers at the site of tissue injury in mice.
FEBS Lett. [Epub ahead of print], 2025.
Journal metrics:
Q1 Biochemistry (2024)
D1 Biophysics (2024)
Q2 Cell Biology (2024)
Q2 Genetics (2024)
Q2 Molecular Biology (2024)
Q2 Structural Biology (2024)
17.
Hoffka, G., Hornyák, L., Székvölgyi, L., Miskei, M.: Phosphorylation of ITIM motifs drives the structural transition of indoleamine 2,3-dioxygenase 1 between enzymatic and non-enzymatic states.
Protein Sci. 34 (6), 1-13, 2025.
Journal metrics:
D1 Biochemistry (2024)
D1 Medicine (miscellaneous) (2024)
D1 Molecular Biology (2024)
18.
Mahdi, M., Kiarie, I. W., Mótyán, J. A., Hoffka, G., Al-Muffti, A. S., Tóth, A., Tőzsér, J.: Receptor Binding for the Entry Mechanisms of SARS-CoV-2: Insights from the Original Strain and Emerging Variants.
Viruses-Basel. 17 (5), 1-25, (article identifier: 691), 2025.
Journal metrics:
Q1 Infectious Diseases (2024)
Q1 Virology (2024)
19.
Ahmad, H., Alatshan, A., Bíró, E., Benkő, S.: Retinoic acid differently modulates NOD1/NOD2-mediated inflammatory responses in human macrophage subsets.
Front. Immunol. 16, 1-11, (article identifier: 1609763), 2025.
Journal metrics:
Q1 Immunology (2024)
Q1 Immunology and Allergy (2024)
20.
Biwott, K., Lkhamkhuu, A., Ghaffar, N., Papp, A. B., Tarban, N., Goda, K., Bacsó, Z.: Ruxolitinib Modulates P-Glycoprotein Function, Delays T Cell Activation, and Impairs CCL19 Chemokine-Directed Migration in Human Cytotoxic T Lymphocytes.
Int. J. Mol. Sci. 26 (13), 1-21, (article identifier: 6123), 2025.
Journal metrics:
Q2 Catalysis (2024)
Q1 Computer Science Applications (2024)
Q1 Inorganic Chemistry (2024)
Q1 Medicine (miscellaneous) (2024)
Q2 Molecular Biology (2024)
D1 Organic Chemistry (2024)
Q1 Physical and Theoretical Chemistry (2024)
D1 Spectroscopy (2024)
21.
Vinnai, B. Á., Arianti, R., Fischer-Posovszky, P., Wabitsch, M., Fésüs, L., Kristóf, E.: The importance of thiamine availability in the thermogenic competency of human adipocytes.
Mol. Cell. Endocrinol. 599, 1-14, (article identifier: 112483), 2025.
Journal metrics:
Q1 Biochemistry (2024)
Q2 Endocrinology (2024)
Q2 Molecular Biology (2024)
22.
Lente, G., Tóth, A., Balogh, E., Csiki, D. M., Nagy, B. J., Szöőr, Á., Jeney, V.: The OsteoSense Imaging Agent Identifies Organ-Specific Patterns of Soft Tissue Calcification in an Adenine-Induced Chronic Kidney Disease Mouse Model.
Int. J. Mol. Sci. 26 (17), 1-14, (article identifier: 8525), 2025.
Journal metrics:
Q2 Catalysis (2024)
Q1 Computer Science Applications (2024)
Q1 Inorganic Chemistry (2024)
Q1 Medicine (miscellaneous) (2024)
Q2 Molecular Biology (2024)
D1 Organic Chemistry (2024)
Q1 Physical and Theoretical Chemistry (2024)
D1 Spectroscopy (2024)
23.
Szojka, Z., Kunkli, B., Kiarie, I. W., Linkner, T. R., Al-Muffti, A. S., Ahmad, H., Benkő, S., Jansson, M., Tőzsér, J., Mahdi, M.: Transcriptomic Analysis Reveals Key Pathways Influenced by HIV-2 Vpx.
Int. J. Mol. Sci. 26 (8), 1-21, (article identifier: 3460), 2025.
Journal metrics:
Q2 Catalysis (2024)
Q1 Computer Science Applications (2024)
Q1 Inorganic Chemistry (2024)
Q1 Medicine (miscellaneous) (2024)
Q2 Molecular Biology (2024)
D1 Organic Chemistry (2024)
Q1 Physical and Theoretical Chemistry (2024)
D1 Spectroscopy (2024)
24.
Csaholczi, B., Csuth, A. R., Korponay-Szabó, I., Fésüs, L., Király, R.: Transglutaminase 2 is an RNA-binding protein: experimental verification and characterisation of a novel transglutaminase feature.
FEBS J. 292 (4), 915-928, 2025.
Journal metrics:
D1 Biochemistry (2024)
Q1 Cell Biology (2024)
Q1 Molecular Biology (2024)
25.
Lengyel, M., Molnár, Á., Nagy, T., Jdeed, S., Garai, I., Horváth, Z., Uray, I. P.: Zymogen granule protein 16B (ZG16B) is a druggable epigenetic target to modulate the mammary extracellular matrix.
Cancer Sci. 116 (1), 81-94, 2025.
Journal metrics:
Q2 Cancer Research (2024)
D1 Medicine (miscellaneous) (2024)
Q1 Oncology (2024)
DEENK University of Debrecen
© 2012 University of Debrecen